Inicio  /  Cancers  /  Vol: 13 Par: 6 (2021)  /  Artículo
ARTÍCULO
TITULO

Mutations Associated with No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer

Guangsheng Zhu    
Dian Ren    
Xi Lei    
Ruifeng Shi    
Shuai Zhu    
Ning Zhou    
Lingling Zu    
Ramon Andrade De Mello    
Jun Chen and Song XU    

Resumen

With the application of immunotherapy in patients with non-small-cell lung cancer (NSCLC), we found that immunotherapy for some patients cannot achieve long-term effects. Therefore, the purpose of this study is to explore the characteristics of these patients and make a model that can effectively predict the prognosis of immunotherapy patients. The results of this study will make it easier for clinicians to screen out NSCLC patients for immunotherapy.

PÁGINAS
pp. 0 - 0
REVISTAS SIMILARES

 Artículos similares